[Form 4] Health Catalyst, Inc. Insider Trading Activity

Nelson Steven H reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Nelson Steven H reported acquisition or exercise transactions in this Form 4 filing.

Health Catalyst, Inc. director Steven H. Nelson received an equity grant of 154,808 restricted stock units of common stock as compensation. The units were granted at no cash cost under the company’s 2019 Stock Option and Incentive Plan and are subject to multi‑year vesting.

According to the award terms, 33.33% of the RSUs will vest on May 1, 2027. The remaining 66.67% will then vest in two equal annual installments, so Nelson’s ability to receive all underlying shares depends on continued service through these future vesting dates.

Insider Trade Summary

Grant/Award: 154,808 shares

Grant/Award 1 txn

Insider Nelson Steven H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	154,808	$0.00	$0.00

Holdings After Transaction: Common Stock — 154,808 shares (Direct)

Footnotes (1)

1. F1. Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 33.33% of the RSUs will vest on May 1, 2027 and, thereafter, the remaining 66.67% of the RSUs will vest in 2 equal annual installments.

Key Figures

RSU grant size: 154,808 units Grant price per unit: $0.00 per unit Initial vesting tranche: 33.33% +3 more

6 metrics

RSU grant size 154,808 units Restricted stock units of common stock granted to director

Grant price per unit $0.00 per unit Equity compensation, no cash paid by recipient

Initial vesting tranche 33.33% Vests on May 1, 2027 under 2019 Plan terms

Remaining vesting portion 66.67% Vests in two equal annual installments after May 1, 2027

Shares after transaction 154,808 shares Total common stock reported as held after the grant

Form type Form 4 Insider grant/award acquisition reporting

Key Terms

restricted stock units ("RSUs"), 2019 Stock Option and Incentive Plan, Non-Employee Director Compensation Policy

3 terms

restricted stock units ("RSUs") financial

"Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

2019 Stock Option and Incentive Plan financial

"RSUs granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan")"

Non-Employee Director Compensation Policy financial

"in accordance with the terms of Issuer's Non-Employee Director Compensation Policy"

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/04/2026 - 05:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nelson Steven H

(Last) (First) (Middle)

10897 S. RIVER FRONT PARKWAY

SUITE 300

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/01/2026		A		154,808(1)	A	$0.00	154,808	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 33.33% of the RSUs will vest on May 1, 2027 and, thereafter, the remaining 66.67% of the RSUs will vest in 2 equal annual installments.

Remarks:

	/s/ Benjamin Landry, as Attorney-in-Fact	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)